1. Home
  2. PRME vs CNNE Comparison

PRME vs CNNE Comparison

Compare PRME & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • CNNE
  • Stock Information
  • Founded
  • PRME 2019
  • CNNE 2014
  • Country
  • PRME United States
  • CNNE United States
  • Employees
  • PRME N/A
  • CNNE N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • CNNE Restaurants
  • Sector
  • PRME Health Care
  • CNNE Consumer Discretionary
  • Exchange
  • PRME Nasdaq
  • CNNE Nasdaq
  • Market Cap
  • PRME 784.4M
  • CNNE 869.9M
  • IPO Year
  • PRME 2022
  • CNNE N/A
  • Fundamental
  • Price
  • PRME $3.77
  • CNNE $17.35
  • Analyst Decision
  • PRME Buy
  • CNNE Buy
  • Analyst Count
  • PRME 6
  • CNNE 3
  • Target Price
  • PRME $9.50
  • CNNE $23.33
  • AVG Volume (30 Days)
  • PRME 3.8M
  • CNNE 468.5K
  • Earning Date
  • PRME 11-07-2025
  • CNNE 11-10-2025
  • Dividend Yield
  • PRME N/A
  • CNNE 3.45%
  • EPS Growth
  • PRME N/A
  • CNNE N/A
  • EPS
  • PRME N/A
  • CNNE N/A
  • Revenue
  • PRME $5,977,000.00
  • CNNE $437,200,000.00
  • Revenue This Year
  • PRME $179.58
  • CNNE N/A
  • Revenue Next Year
  • PRME N/A
  • CNNE N/A
  • P/E Ratio
  • PRME N/A
  • CNNE N/A
  • Revenue Growth
  • PRME 647.13
  • CNNE N/A
  • 52 Week Low
  • PRME $1.11
  • CNNE $15.92
  • 52 Week High
  • PRME $6.94
  • CNNE $22.36
  • Technical
  • Relative Strength Index (RSI)
  • PRME 36.50
  • CNNE 35.05
  • Support Level
  • PRME $4.13
  • CNNE $17.52
  • Resistance Level
  • PRME $5.03
  • CNNE $17.90
  • Average True Range (ATR)
  • PRME 0.43
  • CNNE 0.41
  • MACD
  • PRME -0.18
  • CNNE -0.09
  • Stochastic Oscillator
  • PRME 8.74
  • CNNE 9.70

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.

Share on Social Networks: